Pancreatic Cancer Research

ResearcherUniversity Hospital MagdeburgActive in the last 2 years

Ulf D. Kahlert

ORCID-verified (high confidence, 0.95), identity_conf@1As of 6 November 2026

Matched on ORCID iD 0000-0002-6021-1841; OpenAlex author ID A5008627959. Sources: OpenAlex.

Their work

Papers
7 (first author 0, last author 6)
Trials
0
Grants
0
Labs led
1
Collaborators
27
Papers, trials and grants by year

2022: 1 paper · 2023: 1 paper · 2024: 2 papers · 2025: 3 papers

Papers 7

  1. Vision transformer network discovers the prognostic value of pancreatic cancer pathology sections via interpretable risk scores. Last author DOI 10.1007/s12672-025-03547-3↗
  2. Unlocking Clinical Insights: Lymphocyte-Specific Protein Tyrosine Kinase Candidates as Promising Therapeutic Targets for Pancreatic Cancer Risk Stratification. Last author DOI 10.1089/cbr.2024.0056↗
  3. Human multiethnic radiogenomics reveals low-abundancy microRNA signature in plasma-derived extracellular vesicles for early diagnosis and molecular subtyping o… Last author DOI 10.7554/elife.103737↗
  4. Nanoformulation of dasatinib cannot overcome therapy resistance of pancreatic cancer cells with low LYN kinase expression. Last author DOI 10.1007/s43440-024-00600-w↗
  5. Integrating a microRNA signature as a liquid biopsy-based tool for the early diagnosis and prediction of potential therapeutic targets in pancreatic cancer. Last author DOI 10.1038/s41416-023-02488-4↗
  6. Plasma extracellular vesicle messenger RNA profiling identifies prognostic EV signature for non-invasive risk stratification for survival prediction of patient… Co-author DOI 10.1186/s13045-023-01404-w↗
  7. Sensory Ion Channel Candidates Inform on the Clinical Course of Pancreatic Cancer and Present Potential Targets for Repurposing of FDA-Approved Agents. Last author DOI 10.3390/jpm12030478↗

Closest collaborators

The 25 strongest of 27 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Christoph Kahlert · 4 shared papers, 2022–2025 · strength 0.70
  2. Wenjie Shi · 3 shared papers, 2025 · strength 0.69
  3. Yi Zhun Zhu · 2 shared papers, 2025 · strength 0.45
  4. Maciej Pech · 2 shared papers, 2025 · strength 0.45
  5. Wenjie Shi · 2 shared papers, 2022–2024 · strength 0.44
  6. Marilyn Kaul · 1 shared paper, 2024 · strength 0.28
  7. Huan Zhang · 1 shared paper, 2025 · strength 0.25
  8. Zhiyong Peng · 1 shared paper, 2025 · strength 0.23
  9. Ujjwal Mukund Mahajan · 1 shared paper, 2025 · strength 0.22
  10. Wenjie Shi · 1 shared paper, 2024 · strength 0.19
  11. Marino Venerito · 1 shared paper, 2024 · strength 0.19
  12. Alexander Link · 1 shared paper, 2024 · strength 0.19
  13. Christiane J. Bruns · 1 shared paper, 2024 · strength 0.19
  14. Yue Zhao · 1 shared paper, 2024 · strength 0.19
  15. Thomas Baptist Brunner · 1 shared paper, 2022 · strength 0.16
  16. Doreen William · 1 shared paper, 2023 · strength 0.13
  17. Susanne Roth · 1 shared paper, 2023 · strength 0.13
  18. Adrian M. Seifert · 1 shared paper, 2023 · strength 0.13
  19. Thilo Hackert · 1 shared paper, 2023 · strength 0.13
  20. Fang Cheng Wong · 1 shared paper, 2023 · strength 0.13
  21. Mathieu Pecqueux · 1 shared paper, 2023 · strength 0.13
  22. Yi Han · 1 shared paper, 2023 · strength 0.13
  23. Lena Seifert · 1 shared paper, 2023 · strength 0.13
  24. Georg F. Weber · 1 shared paper, 2023 · strength 0.13
  25. Christian P. Pilarsky · 1 shared paper, 2023 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.